CIK: 0001263508 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value ($000): $7,867,925 (75.6% shares, 24.4% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 20,739,426 | $944,887 | 12.0% | $32.03 | — | COM | 812578102 |
| — | Synageva Biopharma Corp. | 10,648,182 | $883,480 | 11.2% | $45.53 | — | COM | 87159A103 |
| — | Pharmacyclics Inc. | 8,737,888 | $875,711 | 11.1% | $79.47 | — | COM | 716933106 |
| INCY | Incyte Corp. | 14,835,559 | $793,999 | 10.1% | $21.85 | +184.1% | COM | 45337C102 |
| ACAD | Acadia Pharmaceuticals Inc. | 20,481,442 | $498,313 | 6.3% | $14.07 | +79.8% | COM | 004225108 |
| — | Salix 2.75% 5/15/15 | 219,440,000 | $491,957 | 6.3% | $1.52 | — | CONV BONDS | 795435AC0 |
| — | Genomic Health Inc. | 13,654,150 | $359,650 | 4.6% | $31.71 | — | COM | 37244C101 |
| — | Incyte Genomics Notes 1.25% 11/15/2020 144A | 274,500,000 | $350,417 | 4.5% | $1.21 | — | CONV BONDS | 45337CAL6 |
| — | Incyte Genomics Notes 0.375% 11/15/2018 144A | 259,000,000 | $326,745 | 4.2% | $1.20 | — | CONV BONDS | 45337CAK8 |
| — | Incyte Genomics Notes 4.75% 10/1/2015 144A | 40,446,000 | $245,887 | 3.1% | $6.08 | — | CONV BONDS | 45337CAJ1 |
| — | Intermune Inc. | 4,324,843 | $144,752 | 1.8% | $32.82 | — | COM | 45884X103 |
| — | Auxilium 1.5% 7/15/2018 | 97,990,000 | $128,796 | 1.6% | $1.00 | — | CONV BONDS | 05334DAA5 |
| BMRN | Biomarin Pharmaceuticals | 1,883,230 | $128,455 | 1.6% | $65.65 | +12.3% | COM | 09061G101 |
| — | Xoma Corp. | 23,057,572 | $120,130 | 1.5% | $3.73 | — | COM | 98419J107 |
| — | Intermune Inc Notes 2.5% 12/15/17 | 41,000,000 | $107,856 | 1.4% | $1.07 | — | CONV BONDS | 45884XAF0 |
| — | Intercept Pharmaceuticals, Inc. | 256,375 | $84,550 | 1.1% | $44.84 | — | COM | 45845P108 |
| — | Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | 22,898,000 | $77,127 | 1.0% | $2.76 | — | CONV BONDS | 09061GAD3 |
| HALO | Halozyme Therapeutics Inc. | 5,698,139 | $72,366 | 0.9% | $6.50 | +128.4% | COM | 40637H109 |
| VNDA | Vanda Pharmaceuticals, Inc. | 4,445,696 | $72,243 | 0.9% | $7.41 | +91.7% | COM | 921659108 |
| — | Gilead 1.625% 5/1/16 | 21,500,000 | $66,903 | 0.9% | $2.26 | — | CONV BONDS | 375558AP8 |
| BCRX | Biocryst Pharmaceuticals Inc. | 5,867,031 | $62,073 | 0.8% | $2.29 | +365.0% | COM | 09058V103 |
| — | Anacor Pharmaceuticals | 3,095,318 | $61,937 | 0.8% | $17.40 | — | COM | 032420101 |
| — | Medivation 2.625% 4/1/17 | 39,500,000 | $56,288 | 0.7% | $1.27 | — | CONV BONDS | 58501NAA9 |
| — | Repros Therapeutics | 2,778,654 | $49,293 | 0.6% | $18.45 | — | COM | 76028H209 |
| — | Questcor Pharmaceuticals, Inc. | 717,745 | $46,603 | 0.6% | $51.83 | — | COM | 74835Y101 |
| — | Mirati Therapeutics Inc. | 2,380,074 | $45,388 | 0.6% | $15.40 | — | COM | 60468T105 |
| — | Derma Sciences | 3,537,137 | $44,851 | 0.6% | $12.84 | — | COM | 249827502 |
| CERS | Cerus | 8,455,306 | $40,585 | 0.5% | $4.84 | +32.8% | COM | 157085101 |
| GILD | Gilead Sciences Inc. | 556,108 | $39,406 | 0.5% | $36.21 | +50.5% | COM | 375558103 |
| — | Acorda Therapeutics, Inc. | 1,000,000 | $37,910 | 0.5% | $37.91 | — | COM | 00484M106 |
| — | Chelsea Therapeutics | 6,760,394 | $37,317 | 0.5% | $2.86 | — | COM | 163428105 |
| — | Clovis Oncology | 529,990 | $36,712 | 0.5% | $64.09 | — | COM | 189464100 |
| — | Intermune Inc Notes 5% 3/1/15 | 16,860,000 | $30,590 | 0.4% | $1.05 | — | CONV BONDS | 45884XAD5 |
| HRTX | Heron Therapeutics, Inc. | 2,167,784 | $30,153 | 0.4% | $12.60 | 0.0% | COM | 427746102 |
| — | Salix 1.5% 3/15/19 | 15,000,000 | $25,289 | 0.3% | $1.49 | — | CONV BONDS | 795435AE6 |
| — | Aegerion Pharmaceuticals | 513,922 | $23,702 | 0.3% | $62.87 | — | COM | 00767E102 |
| — | Dyax Corp. | 2,531,766 | $22,735 | 0.3% | $7.82 | — | COM | 26746E103 |
| — | Avanir Pharmaceuticals | 5,790,139 | $21,250 | 0.3% | $4.27 | — | COM Class A | 05348P401 |
| — | Xenoport | 4,034,112 | $20,856 | 0.3% | $5.11 | — | COM | 98411C100 |
| — | Progenics Pharmaceuticals, Inc. | 4,449,797 | $18,200 | 0.2% | $4.44 | — | COM | 743187106 |
| — | Aquinox Pharmaceuticals, Inc. | 1,211,851 | $15,427 | 0.2% | $12.73 | — | COM | 03842B101 |
| TGTX | TG Therapeutics | 2,160,965 | $14,911 | 0.2% | $4.61 | +28.5% | COM | 88322Q108 |
| — | Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | 12,500,000 | $13,699 | 0.2% | $1.06 | — | CONV BONDS | 09061GAE1 |
| — | Kythera Biopharmaceuticals | 311,255 | $12,375 | 0.2% | $34.55 | — | COM | 501570105 |
| — | Arrowhead Research Corp. | 732,062 | $12,020 | 0.2% | $5.69 | — | COM | 042797209 |
| INSM | Insmed Inc. | 554,050 | $10,549 | 0.1% | $10.61 | +79.0% | COM | 457669307 |
| — | Tekmire Pharmaceuticals Corp. | 484,156 | $10,405 | 0.1% | $7.97 | — | COM | 87911B209 |
| SGMO | Sangamo Biosceiences, Inc. | 522,764 | $9,452 | 0.1% | $12.44 | +54.9% | COM | 800677106 |
| — | Synergy Pharmaceuticals | 1,758,271 | $9,336 | 0.1% | $4.32 | — | COM | 871639308 |
| OMER | Omeros Corp. | 753,804 | $9,098 | 0.1% | $7.18 | +71.0% | COM | 682143102 |
| PRTA | Prothena Corp. PLC | 230,142 | $8,817 | 0.1% | $9.30 | +246.6% | SHS | G72800108 |
| — | Threshold Pharma | 1,826,358 | $8,693 | 0.1% | $4.65 | — | COM | 885807206 |
| — | QLT Inc. | 1,535,863 | $8,539 | 0.1% | $4.39 | — | COM | 746927102 |
| — | Discovery Laboratories Inc. | 3,652,117 | $7,852 | 0.1% | $1.95 | — | COM | 254668403 |
| AGIO | Agios Pharmaceuticals | 199,893 | $7,826 | 0.1% | $27.47 | +21.8% | COM | 00847X104 |
| GALT | Galectin Therapeutics Inc. | 500,000 | $7,655 | 0.1% | $13.23 | +7.6% | COM | 363225202 |
| INFIQ | Infinity Pharmaceuticals Inc. | 624,050 | $7,420 | 0.1% | $13.42 | 0.0% | COM | 45665G303 |
| NBIX | Neurocrine Biosciences, Inc. | 447,874 | $7,211 | 0.1% | $17.10 | 0.0% | COM | 64125C109 |
| — | Stemline Therapeutics Inc. | 338,671 | $6,895 | 0.1% | $23.84 | — | COM | 85858C107 |
| — | Ambit Biosciences Corp. | 747,954 | $6,821 | 0.1% | $7.00 | — | COM | 02318X100 |
| — | Biota Pharmaceuticals | 1,106,910 | $6,763 | 0.1% | $4.19 | — | COM | 090694100 |
| — | Array Biopharma Inc. | 1,433,797 | $6,739 | 0.1% | $4.54 | — | COM | 04269X105 |
| — | Zogenix, Inc. | 2,350,400 | $6,687 | 0.1% | $2.18 | — | COM | 98978L105 |
| — | Idera Pharmaceuticals Inc. | 1,613,076 | $6,581 | 0.1% | $0.91 | — | COM | 45168K306 |
| XNCR | Xencor | 542,363 | $6,362 | 0.1% | $8.58 | +22.5% | COM | 98401F105 |
| — | Aerie Pharmaceuticals | 299,356 | $6,343 | 0.1% | $17.96 | — | COM | 00771V108 |
| — | Novavax Inc. | 1,223,362 | $5,542 | 0.1% | $3.15 | — | COM | 670002104 |
| IRWD | Ironwood Pharmaceuticals | 446,160 | $5,497 | 0.1% | $11.63 | -3.3% | COM | 46333X108 |
| — | Regado | 400,000 | $5,008 | 0.1% | $12.52 | — | COM | 75874Q107 |
| LGND | Ligand Pharmaceuticals | 73,400 | $4,937 | 0.1% | $41.68 | 0.0% | CLASS B | 53220K504 |
| RARE | Ultragenyx Pharmaceuticals | 100,000 | $4,889 | 0.1% | $51.48 | 0.0% | COM | 90400D108 |
| — | Epizyme Inc. | 214,012 | $4,873 | 0.1% | $21.47 | — | COM | 29428V104 |
| — | Osiris Therapeutics Inc. | 361,530 | $4,747 | 0.1% | $16.64 | — | COM | 68827R108 |
| — | Ignyta | 571,000 | $4,739 | 0.1% | $8.30 | — | COM | 451731103 |
| — | Portola Pharmaceuticals, Inc. | 182,591 | $4,729 | 0.1% | $24.57 | — | COM | 737010108 |
| — | Cytrx Corp. | 1,350,000 | $4,712 | 0.1% | $3.49 | — | COM | 232828509 |
| — | Bluebird Bio Inc. | 198,260 | $4,508 | 0.1% | $25.09 | — | COM | 09609G100 |
| — | Celsus Therapeutics | 673,887 | $4,374 | 0.1% | $6.49 | — | COM | 15119A202 |
| — | Retrophin Inc. | 197,178 | $4,194 | 0.1% | $21.27 | — | COM | 761299106 |
| — | Isis Pharmaceuticals, Inc. | 96,303 | $4,161 | 0.1% | $26.87 | — | COM | 464330109 |
| — | BioDelivery Sciences Intl. Inc. | 421,005 | $3,553 | 0.0% | $4.06 | — | COM | 09060J106 |
| — | Furiex Pharmaceuticals, Inc. | 40,309 | $3,507 | 0.0% | $87.00 | — | COM | 36106P101 |
| ENTA | Enanta Pharmaceuticals | 80,957 | $3,237 | 0.0% | $19.50 | +86.3% | COM | 29251M106 |
| MGNX | Macrogenics, Inc. | 96,165 | $2,676 | 0.0% | $26.16 | +35.0% | COM | 556099109 |
| — | La Jolla Pharmaceuticals, Inc. | 221,631 | $2,394 | 0.0% | $10.80 | — | COM | 503459604 |
| — | Synta Pharmaceuticals | 500,000 | $2,155 | 0.0% | $4.99 | — | COM | 87162T206 |
| — | Mast Therapeutics, Inc. | 3,000,000 | $2,040 | 0.0% | $0.68 | — | COM | 576314108 |
| OSUR | Orasure Technologies Inc. | 234,664 | $1,870 | 0.0% | $4.46 | +56.8% | COM | 68554V108 |
| — | Rigel Pharmaceuticals | 481,972 | $1,870 | 0.0% | $3.58 | — | COM | 766559603 |
| — | Karyopharm Therapeutics | 59,095 | $1,825 | 0.0% | $22.93 | — | COM | 48576U106 |
| — | Auxilium Pharmaceuticals, Inc. | 58,544 | $1,591 | 0.0% | $27.18 | — | COM | 05334D107 |
| — | Achaogen Inc. | 100,000 | $1,546 | 0.0% | $15.46 | — | COM | 004449104 |
| — | Achillion | 438,337 | $1,442 | 0.0% | $8.18 | — | COM | 00448Q201 |
| — | Ophthotech Corp. | 36,776 | $1,314 | 0.0% | $32.35 | — | COM | 683745103 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 569,853 | $1,288 | 0.0% | $2.09 | 0.0% | COM | 14888U101 |
| — | Ziopharm Oncology Inc. | 244,619 | $1,120 | 0.0% | $2.11 | — | COM | 98973P101 |
| — | Receptos Inc. | 23,900 | $1,002 | 0.0% | $19.89 | — | COM | 756207106 |
| FOLD | Amicus Therapeutics | 481,697 | $997 | 0.0% | $3.07 | -18.6% | COM | 03152W109 |
| — | Acceleron Pharma Inc. | 28,765 | $992 | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Tesaro Inc. | 31,218 | $920 | 0.0% | $32.74 | — | COM | 881569107 |
| GERN | Geron Corp. | 402,629 | $837 | 0.0% | $1.08 | +267.5% | COM | 374163103 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,600 | $779 | 0.0% | $77.42 | 0.0% | COM | 02043Q107 |
| — | Ventrus Biosciences, Inc. | 417,690 | $535 | 0.0% | $2.40 | — | COM | 922822101 |
| QURE | Uniquere B.V. | 30,672 | $477 | 0.0% | $15.95 | 0.0% | COM | N90064101 |
| — | Five Prime Therapeutics Inc. | 19,823 | $390 | 0.0% | $16.80 | — | COM | 33830X104 |
| — | Salix Pharmaceuticals | 3,621 | $375 | 0.0% | $66.16 | — | COM | 795435106 |
| — | Chemocentryx Inc. | 50,000 | $332 | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | 13,253 | $113 | 0.0% | $7.20 | — | PFD CONV EX | 23254L207 |